Progyny Inc (PGNY)
32.05
-0.23
(-0.71%)
USD |
NASDAQ |
May 02, 16:00
31.61
-0.44
(-1.37%)
After-Hours: 20:00
Progyny Cash from Operations (Quarterly): 37.66M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 37.66M |
| September 30, 2023 | 54.18M |
| June 30, 2023 | 76.01M |
| March 31, 2023 | 20.96M |
| December 31, 2022 | 51.52M |
| September 30, 2022 | 20.89M |
| June 30, 2022 | 19.25M |
| March 31, 2022 | -11.26M |
| December 31, 2021 | 8.815M |
| September 30, 2021 | 24.16M |
| Date | Value |
|---|---|
| June 30, 2021 | -7.473M |
| March 31, 2021 | 0.532M |
| December 31, 2020 | 6.537M |
| September 30, 2020 | 15.33M |
| June 30, 2020 | 2.197M |
| March 31, 2020 | 12.14M |
| December 31, 2019 | -5.489M |
| September 30, 2019 | 5.879M |
| June 30, 2019 | 4.247M |
| March 31, 2019 | -6.171M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-11.26M
Minimum
Mar 2022
76.01M
Maximum
Jun 2023
17.69M
Average
12.14M
Median
Mar 2020
Cash from Operations (Quarterly) Benchmarks
| Delcath Systems Inc | -8.178M |
| Star Equity Holdings Inc | 0.029M |
| Exact Sciences Corp | 69.55M |
| Illumina Inc | 224.00M |
| CytoSorbents Corp | -6.407M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -93.41M |
| Cash from Financing (Quarterly) | -5.025M |
| Free Cash Flow | 185.17M |
| Free Cash Flow Per Share (Quarterly) | 0.366 |
| Free Cash Flow to Equity (Quarterly) | 36.98M |
| Free Cash Flow to Firm (Quarterly) | 36.98M |
| Free Cash Flow Yield | 5.74% |